Framingham Stroke Risk Profile and poor cognitive function: a population-based study
Llewellyn, David J
Lang, Iain A
Huppert, Felicia Adina
Langa, Kenneth M
MetadataShow full item record
Llewellyn, D. J., Lang, I. A., Xie, J., Huppert, F. A., Melzer, D., & Langa, K. M. (2008). Framingham Stroke Risk Profile and poor cognitive function: a population-based study.
Abstract Background The relationship between stroke risk and cognitive function has not previously been examined in a large community living sample other than the Framingham cohort. The objective of this study was to examine the relationship between 10-year risk for incident stroke and cognitive function in a large population-based sample. Methods Participants were 7377 adults aged 50 years and over of the 2002 wave of the English Longitudinal Study of Ageing, a prospective cohort study. A modified version of the Framingham Stroke Risk Profile (incorporating age, sex, systolic blood pressure, antihypertensive medication, diabetes, smoking status, cardiovascular disease, and atrial fibrillation) was used to assess 10-year risk of stroke. Linear regression models were used to determine the cross-sectional relationship of stroke risk to global cognitive function and performance in multiple cognitive domains. Results In unadjusted models 10 percentage point increments of 10-year stroke risk were associated with poor global cognitive function (-0.40 SD units, 95% CI -0.43 – -0.38), and lowered performance in all cognitive domains. After statistical adjustment for age, sex, testing interval and other correlates of cognitive function the association with stroke risk was attenuated though remained significant for global cognitive function (-0.06 SD units, 95% CI -0.09 – -0.03), immediate and delayed verbal memory, semantic verbal fluency and processing speed. Conclusion In individuals free from a history of stroke or dementia, high subclinical cerebrovascular disease burden was associated with worse cognitive function in multiple domains.
This record's URL: http://www.dspace.cam.ac.uk/handle/1810/237974
Rights Holder: Llewellyn et al.; licensee BioMed Central Ltd.